Evaluating appropriate use of blood products in mothers and babies

Funding Activity

Does something not look right? The information on this page has been harvested from data sources that may not be up to date. We continue to work with information providers to improve coverage and quality. To report an issue, use the .

Funded Activity Summary

There has been an increase in blood transfusions following childbirth. Blood transfusions are potentially life-saving treatments for mothers and babies facing life-threatening illnesses or complications involving haemorrhage, however there is potential to be over-transfusing mothers and babies who are exposed to unnecessary risk of adverse outcomes such as infection. We aim to evaluate and improve the safety and appropriate use of blood and blood products during pregnancy, childbirth and the newborn period.

Funded Activity Details

Start Date: 01-01-2012

End Date: 01-01-2015

Funding Scheme: Partnerships

Funding Amount: $392,137.00

Funder: National Health and Medical Research Council

Research Topics

ANZSRC Field of Research (FoR)

Obstetrics and Gynaecology

ANZSRC Socio-Economic Objective (SEO)

There are no SEO codes available for this funding activity

Other Keywords

blood transfusion | data linkage | haemorrhage | maternal and child health | transfusion